synapticure.bsky.social
Cutting-edge telemedicine for patients with Alzheimer's and related Dementia, Parkinson’s, ALS and more. 🌐 synapticure.com | 📞(855) 255-5917
👤 Joined on 19 November 2024
Followers
Following
Total Posts
@synapticure.bsky.socialSynapticure is excited to share that we will be hosting a webinar on October 28, 2025 with participants in the @Neuralink ongoing ALS trial, along with representatives from the company. The webinar will feature Brad Smith, Jake Schneider, and Nick Wray—three individuals with ALS
Show PostThese are real patients and caregivers who use @synapticure.bsky.social. #thecarewealldeserve
Show PostThese are real patients and caregivers who use @synapticure.bsky.social. #thecarewealldeserve
Show PostOno Pharma Drug Acquired in $2.4B Deal Wins FDA Approval for Treating Rare Type of Tumor https://medcitynews.com/2025/02/ono-pharma-fda-approval-vimseltinib-romvimza-deciphera-tgct-csf1-rare-tumor/
Show Post